Clinical Study
Hepatitis B Infection in Microbiology Laboratory Workers: Prevalence, Vaccination, and Immunity Status
Table 5
Results of hepatitis B serologic tests of all study subjects (
).
| Serologic test | Result | Number of study subjects (%) | Interpretation |
| HBsAg Anti-HBsAb Anti-HBcAb Anti-HBeAb | Negative Negative Negative Negative | 26 (36.1) | Susceptible |
| HBsAg Anti-HBsAb Anti-HBcAb Anti-HBeAb | Negative Positive Positive Positive | 4 (5.6) | Immune due to recent infection |
| HBsAg Anti-HBsAb Anti-HBcAb Anti-HBeAb | Negative Positive Positive Negative | 3 (4.2) | Immune due to remote infection |
| HBsAg Anti-HBsAb Anti-HBcAb Anti-HBeAb | Negative Positive Negative Negative | 35 (48.6)
| Immune due to hepatitis B vaccination |
| HBsAg Anti-HBsAb Anti-HBcAb Anti-HBeAb | Positive Negative Positive Negative | 1 (1.4) | Acutely infected |
| HBsAg Anti-HBsAb Anti-HBcAb Anti-HBeAb | Negative Negative Positive Negative | 3 (4.2) | (1) False positive Anti HBc, therefore susceptible (2) Window period (3) Resolved infection with waning titers of Anti-HBs (4) Occult HBV infection (low levels of HBsAg) |
|
|